<DOC>
	<DOCNO>NCT00673751</DOCNO>
	<brief_summary>The aim study investigate effect enteric hormone Glucagon-like Peptide ( GLP-2 ) patient short bowel syndrome</brief_summary>
	<brief_title>Effect Enteric Hormone Glucagon-Like Peptide ( GLP-2 ) Intestinal Blood Flow Patients With Short Bowel Syndrome</brief_title>
	<detailed_description>previous study show GLP-2 increase mesenteric blow flow , wish examine effect subcutaneus GLP-2 patient short bowl syndrome . The patient single blind give 450 nmol GLP-2 isotonic saline order act reference .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Short Bowel Syndrome</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<criteria>clinical diagnose short bowel syndrome 4 month stable fase activity IBD</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>mesenteric blood flow</keyword>
	<keyword>GLP-2</keyword>
	<keyword>short bowel syndrome</keyword>
	<keyword>Glucagon-Like Peptide 2</keyword>
</DOC>